Innovative Debt Solutions
Tailored Growth Capital
Announcements
Samsung Ventures joins GridBeyond’s shareholder base as part of a €12M equity investment
View Samsung Ventures joins GridBeyond’s shareholder base as part of a €12M equity investmentClaret Capital Partners Invests €28M in Cinclus Pharma
View Claret Capital Partners Invests €28M in Cinclus PharmaClaret Capital Partners Announces Investment in U.S.-based ACT LAB
View Claret Capital Partners Announces Investment in U.S.-based ACT LABNeurent Medical Raises €62.5 million in Oversubscribed Series C Financing to Accelerate NEUROMARK® Commercial Expansion to treat Chronic Rhinitis
View Neurent Medical Raises €62.5 million in Oversubscribed Series C Financing to Accelerate NEUROMARK® Commercial Expansion to treat Chronic RhinitisThe GLP-1 Pill Race: Pharma’s New Frontier
View The GLP-1 Pill Race: Pharma’s New FrontierLiechtenstein’s spectrum award to Open Cosmos propels Europe in the space tele-communications infrastructure race.
View Liechtenstein’s spectrum award to Open Cosmos propels Europe in the space tele-communications infrastructure race.Claret Capital Partners Completes €35M Investment in Holidu to Fuel Growth and M&A
View Claret Capital Partners Completes €35M Investment in Holidu to Fuel Growth and M&AClaret Capital Partners Invests in SIS Medical, Marking 200th Portfolio Company
View Claret Capital Partners Invests in SIS Medical, Marking 200th Portfolio CompanyClaret Capital Partners Named Venture Debt Provider of the Year for Second Year Running!
View Claret Capital Partners Named Venture Debt Provider of the Year for Second Year Running!Deciphex Secures €15M Venture Debt Funding from Claret Capital Partners to Accelerate Growth
View Deciphex Secures €15M Venture Debt Funding from Claret Capital Partners to Accelerate GrowthClaret Capital Partners Announces €10M Growth Funding in Yseop to Scale Generative AI Platform for Life Sciences and Pharma
View Claret Capital Partners Announces €10M Growth Funding in Yseop to Scale Generative AI Platform for Life Sciences and PharmaFund your growth while minimising dilution
Investing in Europe's leading disruptive businesses.
€
0
bn+
Total capital deployed across Europe since inception.
€
0
bn+
AUM
0
+
European SMEs backed across technology, life sciences and climate tech.
Selected investments:
FOUNDER & CEO CORNER
Further Reading
Investment Announcement
23 Mar 2026
Claret Capital Partners Extends €10M in Financing to Wellster Healthtech to Support European Expansion
View Claret Capital Partners Extends €10M in Financing to Wellster Healthtech to Support European Expansion
Portfolio News
17 Mar 2026
Samsung Ventures joins GridBeyond’s shareholder base as part of a €12M equity investment
View Samsung Ventures joins GridBeyond’s shareholder base as part of a €12M equity investment
Investment Announcement
13 Mar 2026
Claret Capital Partners Invests €28M in Cinclus Pharma
View Claret Capital Partners Invests €28M in Cinclus Pharma
Investment Announcement
10 Mar 2026
Claret Capital Partners Announces Investment in U.S.-based ACT LAB
View Claret Capital Partners Announces Investment in U.S.-based ACT LAB
Portfolio News
11 Feb 2026
Neurent Medical Raises €62.5 million in Oversubscribed Series C Financing to Accelerate NEUROMARK® Commercial Expansion to treat Chronic Rhinitis
View Neurent Medical Raises €62.5 million in Oversubscribed Series C Financing to Accelerate NEUROMARK® Commercial Expansion to treat Chronic Rhinitis
Claret Insight
28 Jan 2026
The GLP-1 Pill Race: Pharma’s New Frontier
View The GLP-1 Pill Race: Pharma’s New Frontier
Portfolio News
14 Jan 2026
Liechtenstein’s spectrum award to Open Cosmos propels Europe in the space tele-communications infrastructure race.
View Liechtenstein’s spectrum award to Open Cosmos propels Europe in the space tele-communications infrastructure race.
Investment Announcement
14 Jan 2026
Claret Capital Partners Completes €35M Investment in Holidu to Fuel Growth and M&A
View Claret Capital Partners Completes €35M Investment in Holidu to Fuel Growth and M&A
Investment Announcement
8 Jan 2026
Claret Capital Partners Invests in SIS Medical, Marking 200th Portfolio Company
View Claret Capital Partners Invests in SIS Medical, Marking 200th Portfolio Company
Claret News
9 Nov 2025
Claret Capital Partners Named Venture Debt Provider of the Year for Second Year Running!
View Claret Capital Partners Named Venture Debt Provider of the Year for Second Year Running!
Investment Announcement
2 Oct 2025
Deciphex Secures €15M Venture Debt Funding from Claret Capital Partners to Accelerate Growth
View Deciphex Secures €15M Venture Debt Funding from Claret Capital Partners to Accelerate Growth
Investment Announcement
1 Oct 2025